Are you Dr. Ruggles?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 33 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1341 W Robinhood Dr Ste B6
Stockton, CA 95207Phone+1 209-481-3446Fax+1 209-474-6468
Summary
- Dr. James Ruggles, MD is a board certified psychiatrist in Stockton, California. He is currently licensed to practice medicine in California, Oregon, and Iowa. He is affiliated with Dameron Hospital.
Education & Training
University of California Davis HealthFellowship, Child and Adolescent Psychiatry, 1980 - 1983- University of California Davis HealthResidency, Psychiatry, 1973 - 1975
University of Iowa Hospitals and ClinicsResidency, Psychiatry, 1972 - 1973
Legacy Emanuel Hospital and Health CenterInternship, Transitional Year, 1971 - 1972
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1971
Certifications & Licensure
CA State Medical License 1973 - 2025
OR State Medical License 1975 - 2019
IA State Medical License 1972 - 2001- American Board of Psychiatry and Neurology Psychiatry
- American Board of Psychiatry and Neurology Child Psychiatry
Publications & Presentations
PubMed
- 202 citationsA Randomized Study and Open-Label Extension Evaluating the Long-Term Efficacy of Pramlintide as an Adjunct to Insulin Therapy in Type 1 DiabetesFred W. Whitehouse, Davida F. Kruger, Mark Fineman, Larry Z. Shen, James A. Ruggles
Diabetes Care. 2002-04-01 - 54 citationsPramlintide reduces postprandial glucose excursions when added to insulin lispro in subjects with type 2 diabetes: a dose-timing study.David G. Maggs, Mark Fineman, Jonathan Kornstein, Terrie Burrell, Sherwyn Schwartz
Diabetes/metabolism Research and Reviews. 2004-01-01 - 72 citationsPramlintide reduces postprandial glucose excursions when added to regular insulin or insulin lispro in subjects with type 1 diabetes: a dose-timing study.Christian Weyer, Alan Gottlieb, Dennis Dong Hwan Kim, Karen Lutz, Sherwyn Schwartz
Diabetes Care. 2003-11-01
Press Mentions
Phase III Pivotal Trial of Once Weekly Exenatide in Adolescents Aged 10June 25th, 2021
